Form 8-K - Current report:
SEC Accession No. 0000950170-22-019164
Filing Date
2022-10-03
Accepted
2022-10-03 08:30:35
Documents
14
Period of Report
2022-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20221003.htm   iXBRL 8-K 74700
2 EX-99.1 crnx-ex99_1.htm EX-99.1 28526
3 GRAPHIC img113038668_0.jpg GRAPHIC 20740
  Complete submission text file 0000950170-22-019164.txt   258167

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20221003.xsd EX-101.SCH 2472
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20221003_pre.xml EX-101.PRE 9842
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20221003_lab.xml EX-101.LAB 13350
8 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20221003_htm.xml XML 4726
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 221286078
SIC: 2834 Pharmaceutical Preparations